Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial. (2021)

First Author: Thomas R
Attributed to:  MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(21)00034-6

PubMed Identifier: 33721566

Publication URI: http://europepmc.org/abstract/MED/33721566

Type: Journal Article/Review

Volume: 9

Parent Publication: The Lancet. Global health

Issue: 5

ISSN: 2214-109X